01

ABBVIE

U.S.A

Antibody Engineering

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2030-06-10

GLECAPREVIR; PIBRENTASVIR

US Patent Number : 10039754

Drug Substance Claim :

Drug Product Claim :

Application Number : 209394

Patent Use Code : U-2141

Patent Use Description :

Patent Expiration Date : 2030-06-10

Product Web Link

Corporate PDF

02

ABBVIE

U.S.A

Antibody Engineering

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2032-01-19

GLECAPREVIR; PIBRENTASVIR

US Patent Number : 8648037

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 209394

Patent Use Code : U-2141

Patent Use Description :

Patent Expiration Date : 2032-01-19

Product Web Link

Corporate PDF

03

ABBVIE

U.S.A

Antibody Engineering

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2030-11-06

GLECAPREVIR; PIBRENTASVIR

US Patent Number : 9586978

Drug Substance Claim :

Drug Product Claim :

Application Number : 209394

Patent Use Code : U-3237

Patent Use Description :

Patent Expiration Date : 2030-11-06

Product Web Link

Corporate PDF

04

ABBVIE

U.S.A

Antibody Engineering

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2030-11-06

GLECAPREVIR; PIBRENTASVIR

US Patent Number : 9586978

Drug Substance Claim :

Drug Product Claim :

Application Number : 215110

Patent Use Code : U-3238

Patent Use Description :

Patent Expiration Date : 2030-11-06

Product Web Link

Corporate PDF

05

ABBVIE

U.S.A

Antibody Engineering

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2030-06-10

GLECAPREVIR; PIBRENTASVIR

US Patent Number : 10028937

Drug Substance Claim :

Drug Product Claim :

Application Number : 209394

Patent Use Code : U-2141

Patent Use Description :

Patent Expiration Date : 2030-06-10

Product Web Link

Corporate PDF

06

ABBVIE

U.S.A

Antibody Engineering

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2030-11-06

GLECAPREVIR; PIBRENTASVIR

US Patent Number : 9586978

Drug Substance Claim :

Drug Product Claim :

Application Number : 209394

Patent Use Code : U-2141

Patent Use Description :

Patent Expiration Date : 2030-11-06

Product Web Link

Corporate PDF

07

ABBVIE

U.S.A

Antibody Engineering

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2032-01-19

GLECAPREVIR; PIBRENTASVIR

US Patent Number : 8648037

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 215110

Patent Use Code : U-3238

Patent Use Description :

Patent Expiration Date : 2032-01-19

Product Web Link

Corporate PDF

08

ABBVIE

U.S.A

Antibody Engineering

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2030-06-10

GLECAPREVIR; PIBRENTASVIR

US Patent Number : 10028937

Drug Substance Claim :

Drug Product Claim :

Application Number : 215110

Patent Use Code : U-3238

Patent Use Description :

Patent Expiration Date : 2030-06-10

Product Web Link

Corporate PDF

09

ABBVIE

U.S.A

Antibody Engineering

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2030-06-10

GLECAPREVIR; PIBRENTASVIR

US Patent Number : 10039754

Drug Substance Claim :

Drug Product Claim :

Application Number : 215110

Patent Use Code : U-3238

Patent Use Description :

Patent Expiration Date : 2030-06-10

Product Web Link

Corporate PDF

10

ABBVIE

U.S.A

Antibody Engineering

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2034-03-14

GLECAPREVIR; PIBRENTASVIR

US Patent Number : 10286029

Drug Substance Claim :

Drug Product Claim :

Application Number : 215110

Patent Use Code : U-3238

Patent Use Description :

Patent Expiration Date : 2034-03-14

Product Web Link

Corporate PDF

Glecaprevir

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

3 API Suppliers

2 KDMF

3 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

1 Drugs in Development

INTERMEDIATES

19 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

5 FDF Dossiers

2 FDA Orange Book

1 Europe

2 Canada

RELATED EXCIPIENT COMPANIES

1 Minakem

1 SPI Pharma

1 Seqens

3 DKSH

1 PMC Isochem

2 Faran Shimi Pharmaceutical

2 Boai NKY Pharmaceuticals Ltd

1 Chynops Pharma

6 Gangwal Healthcare

2 Nanjing Well Pharmaceutical

2 Alcedo Pharmachem

4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

2 BASF

1 Bioplus Life Sciences

3 DFE Pharma

2 Gangwal Chemicals

1 Huzhou Sunflower Pharmaceutical

1 Ingredion Pharma Solutions

14 Kerry

3 Microlex e.U

1 NEWEDGE Overseas

1 Novo Excipients

1 Pharmatrans-Sanaq

2 Pluviaendo

2 Prachin Chemical

3 Roquette

1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

4 Sigachi Industries

1 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

29 Fillers, Diluents & Binders

15 Direct Compression

12 Disintegrants & Superdisintegrants

9 Lubricants & Glidants

8 Film Formers & Plasticizers

8 Granulation

7 Coating Systems & Additives

5 Co-Processed Excipients

4 Emulsifying Agents

3 Solubilizers

3 Thickeners and Stabilizers

2 Taste Masking

2 Coloring Agents

2 Topical

2 Controlled & Modified Release

2 Chewable & Orodispersible Aids

2 Parenteral

1 API Stability Enhancers

1 Surfactant & Foaming Agents

1 Rheology Modifiers

DIGITAL CONTENT

3 DATA COMPILATION #PharmaFlow

34 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 Finished Drug Prices

6 Annual Reports

MARKET PLACE

3 APIs

1 FDF Dossiers

PATENTS & EXCLUSIVITIES